CA2115815A1 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- CA2115815A1 CA2115815A1 CA002115815A CA2115815A CA2115815A1 CA 2115815 A1 CA2115815 A1 CA 2115815A1 CA 002115815 A CA002115815 A CA 002115815A CA 2115815 A CA2115815 A CA 2115815A CA 2115815 A1 CA2115815 A1 CA 2115815A1
- Authority
- CA
- Canada
- Prior art keywords
- glu
- gly
- hirudin
- asn
- cys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939303275A GB9303275D0 (en) | 1993-02-18 | 1993-02-18 | Pharmaceutical compositions |
| GB9303275.3 | 1993-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2115815A1 true CA2115815A1 (en) | 1994-08-19 |
Family
ID=10730651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002115815A Abandoned CA2115815A1 (en) | 1993-02-18 | 1994-02-16 | Pharmaceutical compositions |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5472938A (h) |
| EP (1) | EP0624375B1 (h) |
| JP (1) | JP3649343B2 (h) |
| CN (1) | CN1108137A (h) |
| AT (1) | ATE216586T1 (h) |
| AU (1) | AU675471B2 (h) |
| CA (1) | CA2115815A1 (h) |
| DE (1) | DE69430458T2 (h) |
| DK (1) | DK0624375T3 (h) |
| ES (1) | ES2176222T3 (h) |
| FI (1) | FI940726A7 (h) |
| GB (1) | GB9303275D0 (h) |
| HU (1) | HUT66079A (h) |
| IL (1) | IL108610A (h) |
| MX (1) | MX9401244A (h) |
| NO (1) | NO940551D0 (h) |
| NZ (1) | NZ250895A (h) |
| PH (1) | PH30338A (h) |
| PT (1) | PT624375E (h) |
| TW (1) | TW315303B (h) |
| ZA (1) | ZA941087B (h) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9401447D0 (en) | 1994-01-26 | 1994-03-23 | Ciba Geigy Ag | Pharmaceutical compositions |
| GB9401448D0 (en) * | 1994-01-26 | 1994-03-23 | Ciba Geigy Ag | Stable dry powders |
| US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| RU2180218C2 (ru) * | 1997-01-20 | 2002-03-10 | Джапэн Энерджи Корпорейшн | Способ стабилизации гирудина и/или вариантов гирудина, лиофилизированная фармацевтическая композиция, полученная с применением данного способа |
| RU2141326C1 (ru) * | 1997-04-17 | 1999-11-20 | Башева Елена Матвеевна | Способ получения вытяжки из медицинских пиявок и средство с ее использованием |
| NO20013182L (no) | 2000-06-26 | 2001-12-27 | Nokian Tyres Plc | System og fremgangsmåte for konvertering og overföring av driftsdata for dekk |
| RU2268739C2 (ru) * | 2004-01-05 | 2006-01-27 | ООО НВФ "Гируд И.Н." | Лечебный гель "пиявит+" на основе биологически активных веществ, продуцируемых медицинской пиявкой, и способ его получения |
| US7795205B2 (en) * | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2487600A (en) * | 1945-10-09 | 1949-11-08 | Sharp & Dohme Inc | Aqueous thixotropic gel composition |
| US3027229A (en) * | 1957-12-02 | 1962-03-27 | Diamond Lab | Method of preparing hydrated calcium phosphate gels |
| US2987600A (en) * | 1959-03-11 | 1961-06-06 | Corning Glass Works | Capacitor edge sealing |
| ZA883443B (en) * | 1987-05-21 | 1988-11-16 | Merrell Dow Pharmaceuticals Inc. | Cyclic anticoagulant peptides |
| US5204323B1 (en) * | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
| US5192747A (en) * | 1989-10-03 | 1993-03-09 | Merrell Dow Pharmaceuticals Inc. | Anticoagulant peptides |
| US5118790A (en) * | 1990-07-24 | 1992-06-02 | Sri International | Analogs of hirudin |
| US5344644A (en) * | 1991-08-01 | 1994-09-06 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release |
-
1993
- 1993-02-18 GB GB939303275A patent/GB9303275D0/en active Pending
-
1994
- 1994-01-21 TW TW083100511A patent/TW315303B/zh active
- 1994-02-03 JP JP01155494A patent/JP3649343B2/ja not_active Expired - Lifetime
- 1994-02-10 PH PH47746A patent/PH30338A/en unknown
- 1994-02-10 AU AU55083/94A patent/AU675471B2/en not_active Ceased
- 1994-02-10 IL IL108610A patent/IL108610A/en not_active IP Right Cessation
- 1994-02-15 AT AT94301083T patent/ATE216586T1/de active
- 1994-02-15 EP EP94301083A patent/EP0624375B1/en not_active Expired - Lifetime
- 1994-02-15 ES ES94301083T patent/ES2176222T3/es not_active Expired - Lifetime
- 1994-02-15 DK DK94301083T patent/DK0624375T3/da active
- 1994-02-15 PT PT94301083T patent/PT624375E/pt unknown
- 1994-02-15 DE DE69430458T patent/DE69430458T2/de not_active Expired - Lifetime
- 1994-02-16 NZ NZ250895A patent/NZ250895A/xx unknown
- 1994-02-16 CA CA002115815A patent/CA2115815A1/en not_active Abandoned
- 1994-02-16 FI FI940726A patent/FI940726A7/fi unknown
- 1994-02-17 NO NO940551A patent/NO940551D0/no not_active Application Discontinuation
- 1994-02-17 US US08/199,506 patent/US5472938A/en not_active Expired - Lifetime
- 1994-02-17 HU HU9400458A patent/HUT66079A/hu unknown
- 1994-02-17 CN CN94101393A patent/CN1108137A/zh active Pending
- 1994-02-17 MX MX9401244A patent/MX9401244A/es unknown
- 1994-02-17 ZA ZA941087A patent/ZA941087B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ250895A (en) | 1994-06-27 |
| GB9303275D0 (en) | 1993-04-07 |
| IL108610A (en) | 1998-03-10 |
| PT624375E (pt) | 2002-08-30 |
| DK0624375T3 (da) | 2002-07-29 |
| IL108610A0 (en) | 1994-08-26 |
| CN1108137A (zh) | 1995-09-13 |
| DE69430458T2 (de) | 2002-11-21 |
| US5472938A (en) | 1995-12-05 |
| JP3649343B2 (ja) | 2005-05-18 |
| FI940726L (fi) | 1994-08-19 |
| ZA941087B (en) | 1994-08-18 |
| ATE216586T1 (de) | 2002-05-15 |
| JPH06256214A (ja) | 1994-09-13 |
| NO940551L (h) | 1994-08-19 |
| HUT66079A (en) | 1994-09-28 |
| HU9400458D0 (en) | 1994-05-30 |
| AU675471B2 (en) | 1997-02-06 |
| FI940726A7 (fi) | 1994-08-19 |
| DE69430458D1 (de) | 2002-05-29 |
| NO940551D0 (no) | 1994-02-17 |
| EP0624375B1 (en) | 2002-04-24 |
| EP0624375A2 (en) | 1994-11-17 |
| TW315303B (h) | 1997-09-11 |
| ES2176222T3 (es) | 2002-12-01 |
| AU5508394A (en) | 1994-08-25 |
| MX9401244A (es) | 1994-08-31 |
| PH30338A (en) | 1997-04-02 |
| FI940726A0 (fi) | 1994-02-16 |
| EP0624375A3 (en) | 1995-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5708145A (en) | Immunglobulins reactive with protegrins | |
| Isemura et al. | Characterization of a new cysteine proteinase inhibitor of human saliva, cystatin SN, which is immunologically related to cystatin S | |
| Markussen et al. | Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain | |
| CA2115815A1 (en) | Pharmaceutical compositions | |
| CA2002924A1 (en) | Anti-Thrombins | |
| US5693486A (en) | DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins | |
| KR950702579A (ko) | 트롬빈 억제제(thrombin inhibitors) | |
| US5756458A (en) | Stabilized potent GRF analogs | |
| EP0758905B1 (en) | Pharmaceutical compositions comprising hirudin | |
| CA2140971C (en) | A stable freeze-dried hirudin composition | |
| MXPA96003010A (en) | Pharmaceutical compositions | |
| EP0477217B1 (en) | Stabilized, potent grf analogs | |
| US5482923A (en) | Heparin neutralization with platelet factor 4 fragments | |
| AU685079B2 (en) | Peptide inhibitors of CXC intercrine molecules | |
| JP4240165B2 (ja) | 血小板由来白血球貪食能亢進因子の活性化因子 | |
| US6036958A (en) | Tsetse thrombin inhibitor | |
| JPH05310788A (ja) | ヒルジンの類縁体及び抗凝血剤 | |
| CA2443726A1 (en) | Use of the protein uk114 or of fragments thereof for the treatment and prevention of the endotoxic shock | |
| CA2178927A1 (en) | Peptide inhibitors of cxc intercrine molecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |